Informazione:
Errore:
ID
21933
Descrizione
This is an open-label extension to study 49653/461, to assess the long-term safety of rosiglitazone (extended release tablets) in subjects with mild to moderate Alzheimer's Disease. GSK Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00381238?term=NCT00381238&rank=1
collegamento
https://clinicaltrials.gov/ct2/show/NCT00381238?term=NCT00381238&rank=1
Keywords
versioni (1)
- 09/05/17 09/05/17 -
Caricato su
9 maggio 2017
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY-NC 3.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Participation Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease NCT00381238
Participation Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease NCT00381238
Similar models
Participation Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease NCT00381238
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Previous Clinical Trial Participation
C2348568 (UMLS CUI-1)
Previous study
Item
Did the subject participate in previous clinical study 49653/461?
boolean
C2242969 (UMLS CUI [1])
Subject number
Item
Previous subject number/identifer if YES, complete the following:
text
C1709561 (UMLS CUI [1])